8.93  0.63 (7.59%)		08-07 16:00
Open: 8.93 High: 8.97 Volume: 2,154,262		Pre. Close: 8.3 Low: 8.47 Market Cap: 1,513(M)

Short term
Mid term
Targets	6-month :	11.64	1-year :	14.01
Resists	First :	9.97	Second :	12
Pivot price	7.96
Supports	First :	6.69	Second :	5.56
MAs	MA(5) :	8.4	MA(20) :	8.3
	MA(100) :	6.26	MA(250) :	4.39
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	78	D(3) :	62
RSI	RSI(14): 55.5
52-week	High :	12.05	Low :	2.24

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ABSI ] has closed below upper band by 3.3%. Bollinger Bands are 25.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	8.57 - 8.62	8.62 - 8.66
Low:	8.07 - 8.13	8.13 - 8.17
Close:	8.21 - 8.3	8.3 - 8.37

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

Fri, 07 Aug 2026
Absci Corp expected to post a loss of 20 cents a share - Earnings Preview - TradingView

Fri, 07 Aug 2026
Absci Corp (ABSI) Stock News Today - TradingKey

Fri, 07 Aug 2026
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits

Thu, 06 Aug 2026
Earnings Preview: Absci Corp to Report Financial Results Post-market on August 11 - Moomoo

Tue, 04 Aug 2026
Absci (ABSI) to Announce Earnings on Tuesday - MarketBeat

Tue, 04 Aug 2026
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - Moomoo

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	169 (M)
Held by Insiders	1.4872e+008 (%)
Held by Institutions	12 (%)
Shares Short	33,360 (K)
Shares Short P.Month	0 (K)

EPS	-1.1644e+008
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-14 %
Return on Assets (ttm)	346.9 %
Return on Equity (ttm)	-37.4 %
Qtrly Rev. Growth	1.84e+006 %
Gross Profit (p.s.)	-35.11
Sales Per Share	-27.43
EBITDA (p.s.)	-3.5103e+007
Qtrly Earnings Growth	-0.9 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-97 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.33
Price to Cash Flow	18.74

Dividend	0
Forward Dividend	3.575e+007
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.